Fraud in scientific research - birth of the Concordat to uphold research integrity in the United Kingdom

Journal of the Royal Society of Medicine

Volumn 107, Issue 2, 2014, Pages 61-65

  Khajuria, Ankur ^a   Agha, Riaz ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b STOKE MANDEVILLE HOSPITAL   (United Kingdom)

Author keywords

Concordat; fraud; misconduct; public health; research

Indexed keywords

EMPLOYER; FRAUD; HUMAN; PHYSICIAN; PUBLIC HEALTH; PUBLISHING; REVIEW; SCIENTIFIC LITERATURE; SCIENTIFIC MISCONDUCT; SCIENTIST; UNITED KINGDOM; UNITED STATES; WESTERN EUROPE;

CONCORDAT; FRAUD; MISCONDUCT; PUBLIC HEALTH; RESEARCH;

ANIMALS; CONSENSUS; FRAUD; GREAT BRITAIN; GUIDELINES AS TOPIC; HUMANS; PUBLIC HEALTH; PUBLIC POLICY; RESEARCH; SCIENTIFIC MISCONDUCT; TRUST;

EID: 84893548150     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/0141076813511452     Document Type: Review

References (36)

1. Farthing M,Horton R,Smith R.Research misconduct: Britain's failure to act.BMJ. 2000;321:1485-6.
2. Godlee F,Smith J,Marcovitch H.Wakefield's article linking MMR vaccine and autism was fraudulent.BMJ. 2011;342:c7452-c7452.
3. Weissmann G.Science fraud: from patchwork mouse to patchwork data.FASEB J. 2006;20:587-90.
4. Saunders R,Savulescu J.Research ethics and lessons from Hwanggate: what can we learn from the Korean cloning fraud?.J Med Ethics. 2008;34:214-21.
5. Martyn C.Fabrication, falsification and plagiarism.QJM. 2003;96:243-4.
6. Wakefield AJ,Murch SH,Anthony A, et al.Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.Lancet. 1998;351:637-41.
7. Fitzpatrick M.MMR: risk, choice, chance.Br Med Bull. 2004;69:143-53.
8. Deer B.How the case against the MMR vaccine was fixed.BMJ. 2011;342:c5347-c5347.
9. Fang FC,Steen RG,Casadevall A.Misconduct accounts for the majority of retracted scientific publications.Proc Natl Acad Sci USA. 2012;109:17028-33.
10. Hilton S,Hunt K,Langan M,Hamilton V,Petticrew M.Reporting of MMR evidence in professional publications: 1988-2007.Arch Dis Child. 2009;94:831-3.
11. Oakley GP,Johnston RB.Balancing benefits and harms in public health prevention programmes mandated by governments.BMJ. 2004;329:41-3; discussion 43-4.
12. Harsoor S,Gangadhar S.Fraud in anaesthetic research and publication.Indian J Anaesth. 2012;56:1-3.
13. Boldt J,Suttner S,Brosch C,Lehmann A,Rohm K,Mengistu A.Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.Anesth Analg. 2009;109:1752-62.
14. Perel P,Roberts I.Colloids versus crystalloids for fluid resuscitation in critically ill patients.Cochrane Database Syst Rev. 2007;4:CD000567-CD000567.
15. Zarychanski R,Abou-Setta AM,Turgeon AF, et al.Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.JAMA. 2013;309:678-88.
16. Retraction. Sawada S,Ishikawa C,Tanji H, et al.Overexpression of caveolin-1 in adult T-cell leukemia.Blood. 2010;115:2220-30.
17. Neill US.Publish or perish, but at what cost?.J Clin Invest. 2008;118:2368-2368.
18. Agha R.Annals of Medicine and Surgery - educating and developing leading physicians and surgeons.AMS. 2012;1:1-1.
19. Lexchin J,Bero LA,Djulbegovic B,Clark O.Pharmaceutical industry sponsorship and research outcome and quality: systematic review.BMJ. 2003;326:1167-70.
20. Harris G. Research Ties Diabetes Drug to Heart Woes (online). See http://www.nytimes.com/2010/02/20/health/policy/20avandia.html?pagewanted=all&_r=0 (last checked 2 July 2013).
21. Nissen SE,Wolski K.Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.N Engl J Med. 2007;356:2457-71.
22. Hawkes N.GlaxoSmithKline pays $3bn to settle dispute over rosiglitazone and other drugs.BMJ. 2011;343:d7234-d7234.
23. GlaxoSmithKline to Pay $3bn in US Drug Fraud Scandal (online). See http://www.bbc.co.uk/news/world-us-canada-18673220 (last checked 2 July 2013).
24. Tavare A,Godlee F.Helping institutions tackle research misconduct.BMJ. 2012;345:e5402-e5402.
25. Christie B.Panel needed to combat research fraud.BMJ. 1999;319:1222-1222.
26. Farthing M. Keep it Real (online). See http://www.timeshighereducation.co.uk/420565.article (last checked 2 July 2013).
27. Kleinert S.Committee on Publication Ethics (COPE). COPE's retraction guidelines.Lancet. 2009;374:1876-77.
28. Cressey D. British Science Needs 'Integrity Overhaul' (online). See http://www.nature.com/news/british-science-needs-integrity-overhaul-1.9803 (last checked 2 July 2013).
29. Tavare A.Institutions must do more to eliminate research misconduct, meeting hears.BMJ. 2012;344:e446-e446.
30. A consensus statement on research misconduct in the UK. BMJ 2012; 344: e1111.
31. UK U. The Concordat to Support Research Integrity (online). See http://www.universitiesuk.ac.uk/highereducation/Documents/2012/TheConcordatToSupportResearchIntegrity.pdf (last checked 2 July 2013).
32. Torjesen I.Strategy for boosting integrity of research is launched in UK.BMJ. 2012;345:e4747-e4747.
33. Normile D. Whistleblower Uses YouTube to Assert Claims of Scientific Misconduct (online). See http://news.sciencemag.org/scienceinsider/2012/01/whistleblower-uses-youtube-to-assert.html (last checked 2 July 2013).
34. Alleged Image Fraud by Shigeaki Kato lab at the University of Tokyo (Alleged Research Misconduct) (online). See http://www.youtube.com/watch?v=FXaOqwanWnU (last checked 2 July 2013).
35. Borenstein S. Study: Fraud Growing in Scientific Research Papers (online). See http://www.guardian.co.uk/world/feedarticle/10464024 (last checked 2 July 2013).
36. Bian ZX,Wu TX.Legislation for trial registration and data transparency.Trials. 2010;11:64-64.